FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/08/044871 [Registered on: 24/08/2022] Trial Registered Prospectively
Last Modified On: 23/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy of Bupivacaine vs Ropivacaine for nerve blocks in upper limb surgeries 
Scientific Title of Study   A comparative study between 0.5% Bupivacaine and 0.75% Ropivacaine in ultrasound guided nerve block for patients undergoing upper limb surgeries, a prospective interventional randomized control study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Phani Vijay 
Designation  Post graduate student 
Affiliation  Medicover Hospitals, Hitech City, Hyderabad 
Address  Department of Anaesthesiology, 4th floor, Medicover Hospitals, Ibis Hotel Lane, HUDA Techno Enclave, Hitech city

Hyderabad
TELANGANA
500081
India 
Phone  09585115242  
Fax    
Email  vijjunmaddy@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anantha Sai Tej Narayanam 
Designation  Senior Consultant Anaesthesiologist 
Affiliation  Medicover Hospitals, Hitech City, Hyderabad 
Address  Department of Anaesthesiology, 4th floor, Medicover Hospitals, Ibis Hotel Lane, HUDA Techno Enclave, Hitech city

Hyderabad
TELANGANA
500081
India 
Phone  09585115242  
Fax    
Email  Tejab4u@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Phani Vijay 
Designation  Post graduate student 
Affiliation  Medicover Hospitals, Hitech City, Hyderabad 
Address  Department of Anaesthesiology, 4th floor, Medicover Hospitals, Ibis Hotel Lane, HUDA Techno Enclave, Hitech city

Hyderabad
TELANGANA
500081
India 
Phone  09585115242  
Fax    
Email  vijjunmaddy@gmail.com  
 
Source of Monetary or Material Support  
This trial is not receiving any external funding. The study is being conducted at Medicover Hospital, Hitech City, Hyderabad 
 
Primary Sponsor  
Name  Dr Phani Vijay 
Address  Department of Anaesthesia, Medicover Hospitals, Hitech City, Hyderabad 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Medicover Hospitals  Ibis Hotel Lane, HUDA techno enclave, Hitech city, Hyderabad- 500081 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Phani Vijay  Medicover Hospitals, Hitech City  Department of Anaesthesiology, 4th floor, Medicover Hospitals, Ibis Hotel Lane, Huda techno enclave, Hitech City, Hyderabad- 500081
Hyderabad
TELANGANA 
9666086274

vijjunmaddy@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Medicover (formerly Maxcure) Hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ultrasound guided brachial plexus block anaesthesia using 20ml of 0.5% bupivacaine (along with 20ml of 2% lignocaine with adrenaline) as the anaesthetic agent  Interscalene, axillary or supraclavicular approach for ultrasound guided, single-shot brachial plexus block shall be used, to compare the efficacy of bupivacaine vs ropivacaine in patients undergoing elective upper limb surgery. The effects of the anaesthetic agent following the single shot of block anaesthesia shall be evaluated for a total duration of six hours following administration of anaesthesia in each patient, for the duration of the study. 
Comparator Agent  Ultrasound guided brachial plexus block anaesthesia using 20ml of 0.75% ropivacaine (along with 20ml of 2% lignocaine with adrenaline) as the anaesthetic agent  Interscalene, axillary or supraclavicular approach for ultrasound guided, single-shot brachial plexus block shall be used, to compare the efficacy of bupivacaine vs ropivacaine in patients undergoing elective upper limb surgery. The effects of the anaesthetic agent following the single shot of block anaesthesia shall be evaluated for a total duration of six hours following administration of anaesthesia in each patient, for the duration of the study. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA grade 1 and 2 physical status
Scheduled for elective surgery under brachial plexus block
No h/o allergy or sensitivity to any of the studied local anaesthetics
Patients weighing over 50kg 
 
ExclusionCriteria 
Details  Patients with :
Bleeding disorders
Neuromuscular disorders
Cardiovascular compromise
COPD
Hepatic dysfunction
Renal failure
Patient refusal to participate 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Time duration of analgesia following administration of block shall be assessed in terms of: time after administration of the single shot brachial plexus block- till the time when the patient complains of pain.   After administration of anaesthetic agent,
the patient shall undergo surgery. The presence or absence of pain at the surgical site shall be noted every hour following administration of block- till 6 hours following the block, or till the patient complains of pain- whichever occurs earlier.  
 
Secondary Outcome  
Outcome  TimePoints 
Onset of sensory blockade  after administration of anaesthesia 
onset of motor blockade  after administration of anaesthesia 
Onset of sensory recovery  after administration of anaesthesia 
Onset of motor recovery  after administration of anaesthesia 
Peak of sensory block  after administration of anaesthesia 
Peak of motor block  after administration of anaesthesia 
Visual analog score at 6 hours  6 hours after administration of anaesthesia 
Need for rescue analgesia  after administration of anaesthesia 
Hemodynamic stability  after administration of anaesthesia 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/08/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
INTRODUCTION: 

Bupivacaine is an amide local anaesthetic frequently used for brachial plexus nerve
block as it offers the advantage of providing a long duration of action and a favourable
ratio of sensory to motor neural block . Bupivacaine binds to the intracellular portion of
sodium channels and blocks sodium influx into nerve cells, which prevents
depolarization. Bupivacaine is metabolized primarily in the liver via conjugation with
glucuronic acid.

Ropivacaine is a long-acting amide local anaesthetic with a potentially improved safety
profile when compared to bupivacaine . Ropivacaine is less lipophilic than bupivacaine
and is less likely to penetrate large myelinated motor fibres, resulting in a relatively
reduced motor blockade. Ropivacaine has a greater degree of motor sensory
differentiation. It has selective action on the pain-transmitting A Delta and C nerves
rather than Aβ fibres, which are involved in motor function.

AIMS AND OBJECTIVES OF THE STUDY:

To compare the efficacy of 20 ml 0.5 % bupivacaine and 20 ml 2 % lignocaine with
adrenaline vs 20 ml 0.75% Ropivacaine and 20 ml 2 % lignocaine with adrenaline.
1. To compare the efficacy in duration of analgesia
2. To compare the onset of sensory and motor blockade and any side effects.
3. To compare the hemodynamic instability

MATERIALS AND METHODS:
60 patients aged between 18-60 years with comparable demographic
variables, undergoing upper extremity surgery under brachial plexus block at
MEDICOVER HOSPITAL,HITECH CITY, HYDERABAD shall be randomly allocated to two
groups of 30 each. Data shall be collected regarding the efficacy of each modality of anaesthesia, tabulated, and statistically analyzed to assess if one form of anaesthesia is superior to the other. 

Administration of block: 
Supraclavicular, axillarly or interscalene approach shall be used
Ultrasound guidance shall be used.

Data pertaining to efficacy of each anaesthetic agent shall be documented, and analyzed statistically to assess efficacy in various parameters including:
Onset of sensory blockade
Onset of motor blockade
Onset of sensory recovery
Onset of motor recovery
Onset of peak sensory block
Duration of analgesia
Need for rescue analgesia
Hemodynamic stability.




 
Close